Aeolus Pharmaceuticals, Inc. (AOLS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 6, 2026
Aeolus Pharmaceuticals Revenue
Aeolus Pharmaceuticals had revenue of $13.00K in the quarter ending June 30, 2017, a decrease of -98.03%. This brings the company's revenue in the last twelve months to $771.00K, down -68.71% year-over-year. In the fiscal year ending September 30, 2016, Aeolus Pharmaceuticals had annual revenue of $2.08M, down -33.27%.
Revenue (ttm)
771.00K
Revenue Growth
-68.71%
P/S Ratio
0.02
Revenue / Employee
192.75K
Employees
4
Market Cap
15.21K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2016 | 2.08M | -1.04M | -33.27% |
| Sep 30, 2015 | 3.11M | -6.52M | -67.70% |
| Sep 30, 2014 | 9.63M | 5.70M | 145.19% |
| Sep 30, 2013 | 3.93M | -3.37M | -46.14% |
| Sep 30, 2012 | 7.29M | 2.47M | 51.28% |
| Sep 30, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Vaxart | 148.20M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Stem Cell Authority | 3.33M |